Elevated hypoxia-inducible factor-1α in pediatric patients with patent ductus arteriosus: a pilot study

PHARMACOLOGICAL REPORTS · Published 2026-07-29 · DOI 10.1007/s43440-026-00883-1

Free full text

Authors (8)

Oksana Trębacz, Patrycja Florek, Jacek Podlewski, Teresa Iwaniec, Wojciech Tarała, Piotr Weryński, Łukasz Niemiec, Bernadeta Szewczyk

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Trębacz, O., Florek, P., Podlewski, J., et al. (2026). Elevated hypoxia-inducible factor-1α in pediatric patients with patent ductus arteriosus: a pilot study. PHARMACOLOGICAL REPORTS. https://doi.org/10.1007/s43440-026-00883-1

Related articles

• Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases · Journal of Clinical Medicine Research · 2026 · Cites or is cited by this article
• Diurnal variation of cisplatin-induced anti-tumor effect and renal toxicity in mice bearing human colon cancer cells · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Targeting mitochondrial deubiquitinase USP30 to induce mitophagy in heteroplasmic mitochondrial diseases · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Potential antidepressant properties of aminophylline in male mice exposed to chronic restraint stress · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• The effect of salidroside, an active component of Rhodiola rosea, on the metabolic activity of rat and human cytochromes P450 in preclinical studies · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Cannabidiol (CBD) modulates the serotonin–kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Targeting epigenetic and DNA topology mechanisms: histone deacetylases and topoisomerase inhibitors in combination and dual inhibition approaches · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Kisspeptin-10 regulates glycosaminoglycan and decorin content in human cardiac fibroblast cultures · PHARMACOLOGICAL REPORTS · 2026 · Same journal